Comparison of pyruvate kinase variants from breast tumor and normal breast

Archives of Medical Research

Volumn 34, Issue 4, 2003, Pages 315-324

  Yilmaz, Seval ^a   Ozan, Sema ^a   Ozercan, Ibrahim Hanifi ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Human breast; Molecular weight; Purification; Pyruvate kinase; Tumor

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMMONIUM SULFATE; CYSTEINE; ENZYME VARIANT; ISOENZYME; PHENYLALANINE; PYRUVATE KINASE; PYRUVIC ACID; SEPHADEX;

AFFINITY CHROMATOGRAPHY; ARTICLE; BREAST; BREAST CARCINOMA; BREAST TUMOR; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE; DIALYSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME PURIFICATION; GEL FILTRATION; HUMAN; HUMAN TISSUE; ION EXCHANGE; MOLECULAR WEIGHT; PRECIPITATION; SPECTROPHOTOMETRY; TISSUE SPECIFICITY;

EID: 0042691363     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(03)00054-7     Document Type: Article

References (38)

1. Marchut E., Guminska M., Kedryna T., Radzikowski C., Kusnierczyk H. A pyruvate kinase variant in different mouse transplanted tumors. Ex perientia. 44:1988;25-27.
2. Guminska M., Stachurska M.B., Christensen B., Tromholt V., Kieler J., Radzikowski C., Dus D. Pyruvate kinase inhibited by L-cysteine as a marker of tumorigenic human urathelial cell lines. Experientia. 45:1989;571-574.
3. Imamura K., Tanaka T. Pyruvate kinase isozymes from rat. Wood M.A. Methods in enzymology. 1982;150-165 Academic Press, New York.
4. Carbanell J., Feliu J.E., Marco R., Sols A. Pyruvate kinase classes of regulatory isoenzyme in mammalian tissues. Eur J Biochem. 37:1973;148-156.
5. Cuenllas E., Gaitan S., Bueren J.A., Tejero C. Kinetic studies of pyruvate kinase during in vitro differentiation of GM-CFC haemopoietic precursor and bone marrow cells in mice. Biosci Rep. 10:1990;141-154.
6. Van Veelen C.W., Rijksen G., Staal G.E. Discrimination between neuronal and glial cell tumours by pyruvate kinase electrophoresis. Acta Neurochir. 91:1988;126-129.
7. Beemer F.A., Vlug A.M., Rijksen G., Hamburg A., Staal G.E. Characterization of some glycolytic enzymes from human retina and retinoblastoma. Cancer Res. 42:1982;4228-4232.
8. Staal G.E., Rijksen G., Van Oirschol B.A., Roholl P.J. Characterization of pyruvate kinase from human rhabdomyosarcoma in relation to immunohistochemical and morphological criteria. Cancer. 63:1989;479-483.
9. Verhagen J.N., Van Der Hejden M.C., Dijken J., Rijksen G., Kinderen P.J., Van Unnik J.A., Staal G.A. Pyruvate kinase in normal human thyroid tissue and thyroid neoplasms. Cancer. 55:1985;142-148.
10. López-Alarcón L., Ruiz P., Gosalvez M. Quantitative determination of the degree of differentiation of mammary tumours by pyruvate kinase kinetic analysis. Cancer Res. 4:1981;2019-2020.
11. Farina F.A., Shatton J.B., Morris H., Weinhouse S. Isozymes of pyruvate kinase in liver and hepatomas of the rat. Cancer Res. 34:1974;1439-1446.
12. 2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J Biol Chem. 261:1986;13807-13812.
13. Oskam R., Van Els C.A., Rijksen G., Staal G.E. Pyruvate kinase isozymes and dedifferentiation of (neuro)-ectodermal tumors. Tumor Biol. 6:1985;75-87.
14. Hennipman A., Van Oirschot B.A., Smits J., Rijksen G., Staal G.E. Heterogeneity of glycolytic enzyme activity and isozyme composition of pyruvate kinase in breast cancer. Tumour Biol. 9:1988;178-189.
15. Ibsen K.H., Orlando R.A., Garratt K.N., Hernández A.M., Giorlando S., Nungaray G. Expression of multimolecular forms of pyruvate kinase in normal, benign and malignant human breast tissue. Cancer Res. 42:1982;888-892.
16. Balinsky D., Platz C.E., Lewis J.W. Isozyme patterns of normal, benign and malignant human breast tissues. Cancer Res. 43:1983;5895-5901.
17. Weber G., Burt M.E., Jackson R.C., Pradja N., Lui M.S., Fakede E. Purine and pyrimidine enzymatic programs and nucleotide pattern in sarcoma. Cancer Res. 43:1983;1010-1023.
18. Van Veelen C.W., Verbiest H., Vlug A.M., Rijksen G., Staal G.E. Isozymes of pyruvate kinase from human brain, and malignant gliomas. Cancer Res. 38:1978;4681-4687.
19. Kedryna T., Guminska M., Marchut E. The inhibitory effect of L-cysteine and its derivatives on glycolysis in Ehrlich ascites tumour cells. Biochim Biophys Acta. 763:1983;64-71.
20. Marchut E., Guminska M., Kedryna T. The inhibitory effect of various fatty acids on aerobic glycolysis in Ehlich ascites tumour cells. Acta Biochim Pol. 33:1986;7-16.
21. Larner E.H., Rutherford C.L. Application of a microchemical technique to the elucidation of enzyme activity profiles within single human mammary tumors. Cancer. 41:1978;1863-1870.
22. Beutler E., Blume K.G., Kaplan J.C., Löhr G.W., Ramot B., Valentine W.N. International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis. Br J Haematol. 35:1977;311-340.
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenylalanine reagent. J Biol Chem. 193:1951;265-275.
24. Weinhouse S. What are isoenzymes telling us about gene regulation in cancer? J Natl Cancer Inst. 68:1982;343-349.
25. Schapira F. Isoenzymes and cancer. Adv Cancer Res. 18:1973;77-153.
26. Weber G. Enzymology of cancer cells (first of two parts). N Engl J Med. 296:1977;486-492.
27. Weber G. Enzymology of cancer cells (second of two parts). N Engl J Med. 296:1977;541-551.
28. Ibsen K.H. Interrelationships and functions of the pyruvate kinase isozymes and their variant forms: a review. Cancer Res. 37:1977;341-353.
29. Hilf R., Wittliff J.L., Rector W.D., Savlov E.D., Hall T.C., Orlando R.A. Studies on certain cytoplasmic enzymes and specific estrogen receptors in human breast cancer and in nonmalignant diseases of the breast. Cancer Res. 33:1973;2054-2062.
30. Warchod T. The influence of transplantable Morris hepatoma on the pentose-phosphate cycle in rat erythrocytes. Ann Med Sect Pol Acad Sci. 20:1975;39.
31. Van Veelen C.W., Verbiest H., Zulch K.J., Van Ketel B.A., Van Der Vlist M.J., Vlug A.M., Rijksen G., Staal G.A. α-Alanine inhibition of pyruvate kinase from tumors of the human central nervous system: a new aid in the treatment of gliomas. Brock M. Modern neurosurgery. 1982;110-121 Springer-Verlag, Berlin, Germany.
32. Van Veelen C.W., Verbiest H., Zulch K.J. α-Alanine inhibition of pyruvate kinase from tumors of the human central nervous system. Cancer Res. 39:1979;4263-4269.
33. Elbers J.R., Van Unnik J.A., Rijksen G., Van Oirschot B.A., Roholl P.J., Oosting J., Staal G.E. Pyruvate kinase activity and isozyme composition in normal fibrous tissue and fibroblastic proliferations. Cancer. 67:1991;2552-2559.
34. Cottreau D., Rousseau-Merck M.F., Nezelof C., Kahn A. Pyruvate kinase and phosphofructokinase isoenzymes in childhood cancer. Pediatr Res. 16:1982;199-202.
35. Eigenbrodt E., Fister P., Reinacker M. New perspectives on carbohydrate metabolism in tumor cells. Breitner R. Regulation of carbohydrate metabolism. 1985;141-179 CRC Press, Boca Raton, FL, USA.
36. Yanagi S., Makiura S., Arai M., Matsumuru K., Hirao K. Isozyme patterns of pyruvate kinase in various primary liver tumors induced during the process of hepatocarcinogenesis. Cancer Res. 34:1974;2283-2289.
37. Gosalvez M., García-Suares S., López-Alarcón L. Metabolic control of glycolysis in normal and tumour permeabilized cells. Cancer Res. 38:1978;142-148.
38. Atkinson D.E. The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry. 7:1968;4030-4034.